Rep. Lisa C. McClain Buys Globus Medical, Inc. (NYSE:GMED) Shares

Key Points

• Rep. Lisa C. McClain purchased between $1,001 and $15,000 in shares of Globus Medical, Inc. (NYSE:GMED) on June 17th, as disclosed in a filing on August 13th.
• Globus Medical's stock opened at $60.77, with a market capitalization of $8.21 billion and reported $0.86 earnings per share for the last quarter, exceeding analyst expectations.
• A share buyback program authorizing the repurchase of $500 million of outstanding shares reflects the company's belief that its stock is undervalued.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Globus Medical, Inc. NYSE: GMED. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Globus Medical stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Globus Medical Stock Down 1.1%

Shares of NYSE:GMED traded down $0.68 during trading on Monday, reaching $61.84. 407,626 shares of the company traded hands, compared to its average volume of 1,438,389. The firm has a market capitalization of $8.35 billion, a PE ratio of 23.80, a PEG ratio of 1.74 and a beta of 1.20. Globus Medical, Inc. has a 52 week low of $51.79 and a 52 week high of $94.93. The company's 50 day moving average is $57.30 and its two-hundred day moving average is $66.08.

Globus Medical (NYSE:GMED - Get Free Report) last released its earnings results on Thursday, August 7th. The medical device company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.10. The company had revenue of $745.34 million for the quarter, compared to analyst estimates of $738.91 million. Globus Medical had a return on equity of 10.65% and a net margin of 13.58%.Globus Medical's quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.75 EPS. As a group, research analysts anticipate that Globus Medical, Inc. will post 3.44 EPS for the current year.

Globus Medical declared that its Board of Directors has authorized a stock buyback plan on Thursday, May 15th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the medical device company to repurchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its shares are undervalued.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Canaccord Genuity Group reduced their target price on Globus Medical from $97.00 to $90.00 and set a "buy" rating on the stock in a report on Tuesday, July 22nd. Morgan Stanley reduced their target price on Globus Medical from $75.00 to $68.00 and set an "overweight" rating on the stock in a report on Tuesday, July 15th. Piper Sandler reduced their target price on Globus Medical from $100.00 to $80.00 and set an "overweight" rating on the stock in a report on Friday, May 9th. Needham & Company LLC reaffirmed a "hold" rating on shares of Globus Medical in a report on Monday, July 21st. Finally, Wells Fargo & Company reduced their target price on Globus Medical from $76.00 to $66.00 and set an "overweight" rating on the stock in a report on Friday, August 8th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Globus Medical has an average rating of "Moderate Buy" and a consensus price target of $87.64.

Institutional Investors Weigh In On Globus Medical

Several hedge funds and other institutional investors have recently modified their holdings of GMED. EverSource Wealth Advisors LLC increased its holdings in shares of Globus Medical by 74.3% during the second quarter. EverSource Wealth Advisors LLC now owns 462 shares of the medical device company's stock valued at $27,000 after acquiring an additional 197 shares in the last quarter. Advisors Asset Management Inc. purchased a new position in shares of Globus Medical during the second quarter valued at approximately $28,000. Farther Finance Advisors LLC boosted its position in shares of Globus Medical by 145.5% during the first quarter. Farther Finance Advisors LLC now owns 405 shares of the medical device company's stock valued at $30,000 after buying an additional 240 shares during the last quarter. Larson Financial Group LLC boosted its position in shares of Globus Medical by 1,007.7% during the first quarter. Larson Financial Group LLC now owns 432 shares of the medical device company's stock valued at $32,000 after buying an additional 393 shares during the last quarter. Finally, Parallel Advisors LLC boosted its position in shares of Globus Medical by 62.1% during the first quarter. Parallel Advisors LLC now owns 504 shares of the medical device company's stock valued at $37,000 after buying an additional 193 shares during the last quarter. Institutional investors own 95.16% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Globus Medical

Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.